They thus provided novel evidence for specific cardioprotective mechanisms involving the eCB-CB2 axis in these two types of cardiovascular cells during the developmental phases of ischaemic cardiomyopathy [60]. This evidence concerns the gene CNR2 and cardiomyopathy.